RenovoRx (RNXT) Assets Average (2021 - 2026)
RenovoRx (RNXT) posted Assets Average of $11.0 million for Q1 2026, up 14.29% sequentially from $9.7 million in Q4 2025, and down 8.59% YoY from $12.1 million in Q1 2025.
RenovoRx (RNXT) Assets Average (2021 - 2026) Analysis & Trends
RenovoRx has reported Assets Average for 6 years, with the latest figure at $11.0 million in Q1 2026.
- Quarterly Assets Average fell 8.59% year-over-year to $11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.0 million (down 8.59% YoY) and the FY2025 annual result came in at $8.1 million, up 69.17% from the prior year.
- Assets Average improved to $11.0 million in Q1 2026 per RNXT's latest filing, from $9.7 million in the prior quarter.
- Over five years, Assets Average peaked at $15.1 million in Q1 2022 and troughed at $2.5 million in Q4 2023.
- A 5-year average of $9.2 million and a median of $9.7 million in 2025 frame the typical range for Assets Average.
- The sharpest annual moves came in 2023 and 2025: Assets Average tumbled 69.82% in 2023, then surged 285.87% in 2025.
- Over 5 years, Assets Average stood at $8.3 million in 2022, then sank by 69.82% to $2.5 million in 2023, then surged by 264.07% to $9.1 million in 2024, then increased by 6.35% to $9.7 million in 2025, then rose by 14.29% to $11.0 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $11.0 million, $9.7 million, and $12.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | RenovoRx | 61.32 Mn | 61.32 Mn | 766,000.00 | 12.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.72 Mn |
| Mar 31, 2026 | 11.03 Mn |
| Dec 31, 2025 | 9.65 Mn |
| Sep 30, 2025 | 12.42 Mn |
| Jun 30, 2025 | 14.83 Mn |
| Mar 31, 2025 | 12.07 Mn |
| Dec 31, 2024 | 9.07 Mn |
| Sep 30, 2024 | 11.02 Mn |
| Jun 30, 2024 | 8.40 Mn |
| Mar 31, 2024 | 3.13 Mn |
| Dec 31, 2023 | 2.49 Mn |
| Sep 30, 2023 | 4.92 Mn |
| Jun 30, 2023 | 5.44 Mn |
| Mar 31, 2023 | 5.91 Mn |
| Dec 31, 2022 | 8.26 Mn |
| Sep 30, 2022 | 10.25 Mn |
| Jun 30, 2022 | 12.59 Mn |
| Mar 31, 2022 | 15.12 Mn |
| Dec 31, 2021 | 17.23 Mn |